These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 31893577

  • 1. Long intergenic non-coding RNA 511 correlates with improved prognosis, and hinders osteosarcoma progression both in vitro and in vivo.
    Qiao S, Qi K, Liu C, Xu C, Ma J, Xu X, Li C, Wang Z.
    J Clin Lab Anal; 2020 May; 34(5):e23164. PubMed ID: 31893577
    [Abstract] [Full Text] [Related]

  • 2. Long intergenic non-protein coding RNA 511 promotes the progression of osteosarcoma cells through sponging microRNA 618 to upregulate the expression of maelstrom.
    Guo W, Yu Q, Zhang M, Li F, Liu Y, Jiang W, Jiang H, Li H.
    Aging (Albany NY); 2019 Aug 06; 11(15):5351-5367. PubMed ID: 31386627
    [Abstract] [Full Text] [Related]

  • 3. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142.
    Zhang L, Zhao G, Ji S, Yuan Q, Zhou H.
    Med Sci Monit; 2020 Mar 10; 26():e921594. PubMed ID: 32155139
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of Long Non-Coding RNA NNT-AS1 Correlates with Tumor Progression and Poor Prognosis in Osteosarcoma.
    Ye H, Lin J, Yao X, Li Y, Lin X, Lu H.
    Cell Physiol Biochem; 2018 Mar 10; 45(5):1904-1914. PubMed ID: 29518771
    [Abstract] [Full Text] [Related]

  • 5. Long non-coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR-195-5p.
    Yang C, Wu K, Wang S, Wei G.
    J Cell Biochem; 2018 Jul 10; 119(7):5646-5656. PubMed ID: 29384226
    [Abstract] [Full Text] [Related]

  • 6. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
    Zhang Y, Wang F, Wang L, Zhang Q.
    World J Surg Oncol; 2020 May 01; 18(1):83. PubMed ID: 32357945
    [Abstract] [Full Text] [Related]

  • 7. Long non-coding RNA CTA sensitizes osteosarcoma cells to doxorubicin through inhibition of autophagy.
    Wang Z, Liu Z, Wu S.
    Oncotarget; 2017 May 09; 8(19):31465-31477. PubMed ID: 28415557
    [Abstract] [Full Text] [Related]

  • 8. LncRNA BLACAT1 accelerates the proliferation and migration of osteosarcoma cells through regulating STAT3.
    Dong Z, Wang Y.
    Pathol Res Pract; 2019 Mar 09; 215(3):571-579. PubMed ID: 30665678
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long noncoding RNA LINC00511 involves in breast cancer recurrence and radioresistance by regulating STXBP4 expression via miR-185.
    Liu L, Zhu Y, Liu AM, Feng Y, Chen Y.
    Eur Rev Med Pharmacol Sci; 2019 Sep 09; 23(17):7457-7468. PubMed ID: 31539133
    [Abstract] [Full Text] [Related]

  • 11. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
    Yu W, Zhang Z, Min D, Yang Q, Du X, Tang L, Lin F, Sun Y, Zhao H, Zheng S, He A, Li H, Yao Y, Shen Z.
    Eur J Cancer; 2014 Apr 09; 50(6):1125-36. PubMed ID: 24565852
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. LOXL1-AS1 predicts poor prognosis and promotes cell proliferation, migration, and invasion in osteosarcoma.
    Chen S, Li W, Guo A.
    Biosci Rep; 2019 Apr 30; 39(4):. PubMed ID: 30944201
    [Abstract] [Full Text] [Related]

  • 14. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.
    Zheng SN, Ge DW, Tang J, Yang J, Yan JW, Qiu JJ, Yin ZW, Ni Y, Zhao L, Chen X, Yang L.
    Eur Rev Med Pharmacol Sci; 2019 Jan 30; 23(1):96-104. PubMed ID: 30657551
    [Abstract] [Full Text] [Related]

  • 15. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
    Yang W, Shan Z, Zhou X, Peng L, Zhi C, Chai J, Liu H, Yang J, Zhang Z.
    Cancer Biomark; 2018 Jan 30; 23(4):589-601. PubMed ID: 30475755
    [Abstract] [Full Text] [Related]

  • 16. Long non-coding RNA tumor suppressor candidate 7 functions as a tumor suppressor and inhibits proliferation in osteosarcoma.
    Cong M, Li J, Jing R, Li Z.
    Tumour Biol; 2016 Jul 30; 37(7):9441-50. PubMed ID: 26781978
    [Abstract] [Full Text] [Related]

  • 17. LncRNA FAL1 is a negative prognostic biomarker and exhibits pro-oncogenic function in osteosarcoma.
    Wang Y, Zhao Z, Zhang S, Li Z, Li D, Yang S, Zhang H, Zeng X, Liu J.
    J Cell Biochem; 2018 Nov 30; 119(10):8481-8489. PubMed ID: 29987852
    [Abstract] [Full Text] [Related]

  • 18. Role of taurine upregulated gene 1 as a predictor of poor outcome in osteosarcoma.
    Wang Q, Chen Q.
    J Cancer Res Ther; 2018 Jun 30; 14(Supplement):S405-S409. PubMed ID: 29970697
    [Abstract] [Full Text] [Related]

  • 19. Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.
    Li C, Zhang S, Qiu T, Wang Y, Ricketts DM, Qi C.
    Cancer Biol Ther; 2019 Jun 30; 20(4):413-422. PubMed ID: 30489194
    [Abstract] [Full Text] [Related]

  • 20. Increased expression of lncRNA HULC indicates a poor prognosis and promotes cell metastasis in osteosarcoma.
    Sun XH, Yang LB, Geng XL, Wang R, Zhang ZC.
    Int J Clin Exp Pathol; 2015 Jun 30; 8(3):2994-3000. PubMed ID: 26045809
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.